Identification of small molecules enhancing autophagic function from drug network analysis

Area of Science:

• Biochemistry
• Pharmacology
• Computational Biology

Background:

• Enhancing autophagy presents a promising therapeutic strategy for various human diseases.
• Gene expression profiling is a key biomarker for understanding drug activity and predicting drug mode of action.
• Existing methods for analyzing gene expression profiles to determine drug mode of action are limited.

Purpose of the Study:

• To develop a novel and robust tool for predicting drug mode of action and facilitating drug repositioning.
• To overcome the limitations of current analytical methods for gene expression profiles.

Main Methods:

• A comprehensive dataset of drug-induced expression profiles from human cell lines was compiled.
• A "drug network" was constructed by comparing transcriptional responses across numerous drugs.
• The topology of the drug network was automatically analyzed to classify compounds and predict drug effects.

Main Results:

• The novel tool successfully classified compounds based on their transcriptional responses.
• The tool predicted previously unreported effects for known drugs.
• Fasudil was identified as a novel enhancer of autophagy using this analytical approach.

Conclusions:

• A new computational tool enables effective prediction of drug mode of action and drug repositioning through drug network analysis.
• This approach enhances the understanding of drug activity based on gene expression profiles.
• The identification of fasudil as an autophagy enhancer demonstrates the tool's potential for drug discovery and development.